Turning Point Brands Reports Strong Q4 Earnings, Beats Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 03 2026
0mins
Should l Buy TPB?
Source: Benzinga
Turning Point Brands Inc. experienced a significant decline of 19.20% in its stock price, crossing below the 20-day SMA, amid a broader market downturn with the Nasdaq-100 down 0.22% and the S&P 500 down 0.17%.
The company's recent Q4 earnings report revealed a non-GAAP EPS of $0.95, surpassing expectations by $0.07, and a revenue of $121.01 million, reflecting a 29.2% year-over-year increase. This strong performance indicates the company's ability to maintain profitability and market share despite the current market conditions. Analysts have expressed optimism about Turning Point Brands' future growth potential, anticipating continued benefits from market trends.
Despite the stock's decline, the robust earnings performance and positive analyst outlook suggest that the company remains well-positioned for future growth, potentially attracting investor interest in the long term.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TPB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TPB
Wall Street analysts forecast TPB stock price to rise
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 86.220
Low
110.00
Averages
116.67
High
120.00
Current: 86.220
Low
110.00
Averages
116.67
High
120.00
About TPB
Turning Point Brands, Inc. is a manufacturer, marketer and distributor of branded consumer products. It sells a range of products to adult consumers, consisting of staple products under the brands Zig-Zag and Stoker’s. Its segments include Zig-Zag Products (Zig-Zag) and Stoker’s Products (Stoker’s). Zig-Zag principally markets and distributes rolling papers, tubes, and related products; finished cigars and make-your-own cigar wraps, and other accessories. It introduced Zig-Zag ‘Rillo-sized wraps, which are similar in size to cigarillos, a type of machine-made cigars. Stoker’s manufactures and markets moist snuff tobacco (MST) and contract for and market FRE, its modern oral product and contract for and market loose-leaf chewing tobacco products. Its products are available in approximately 200,000 in the United States retail locations which, with the addition of retail stores in Canada, brings its total North American retail presence to an estimated 220,000 points of distribution.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analysis of Three High-Potential Dividend Stocks
- Turning Point Brands Growth Potential: Despite a slight dip in EPS, Turning Point Brands reported a 29% sales increase in Q4, exceeding analyst expectations by 9%, with modern oral nicotine product sales surging 266% year-over-year, indicating strong growth potential during its transition.
- Crown Holdings Dividend Increase: Crown Holdings announced a 35% dividend increase, achieving approximately $2.1 billion in adjusted EBITDA and $12.365 billion in net sales for 2025, reflecting strong performance in global beverage can demand and confidence in sustainable growth.
- Mondelez Undervalued: Mondelez generated $38.5 billion in revenue in 2025, and despite a 44.7% drop in EPS due to rising cocoa prices, its organic revenue still grew by 4.3%, showcasing strong growth potential in emerging markets and stable cash flow.
- Dividend Investment Opportunities: All three companies demonstrate robust cash flows and solid financial health, with dividend increases from Turning Point Brands and Crown Holdings reflecting management's confidence in future prospects, making them attractive for long-term investors.
See More
Apis Capital Increases Stake in Turning Point Brands Significantly
- Stake Increase: Apis Capital Advisors increased its position in Turning Point Brands by 106,948 shares in Q4 2026, with an estimated transaction value of $10.46 million, raising its stake from 1.3% to 3.1%, indicating strong confidence in the company's growth prospects.
- Market Value Growth: As of March 4, 2026, Turning Point Brands' shares were priced at $97.58, up 38.6% over the past year, outperforming the S&P 500 by 21 percentage points, reflecting market recognition of its strategic transformation.
- Revenue Growth Potential: The company's white nicotine pouch brands, Fre and Alp, achieved a remarkable 266% sales growth in Q4, projected to account for half of total revenue by the end of 2026, highlighting its competitive strength in a rapidly expanding market.
- Valuation Reasonableness: Despite Turning Point Brands' stock selling off over 30% from its Q1 highs, it trades at a forward P/E of 27 times while achieving 29% sales growth in the latest quarter, indicating a reasonably priced growth story that continues to attract investor interest.
See More
Doseology Launches New Energy Pouches Targeting Market Opportunities
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and driving investments and innovations from companies like Doseology.
- Product Innovation and Market Testing: Doseology's launch of Feed That Brain energy pouches in the U.S. marks its first direct-to-consumer initiative, aiming to provide sugar-free, smoke-free energy supplements, signifying the company's strategic positioning in the non-nicotine energy product sector, expected to attract health-conscious consumers.
- Strategic Leadership Change: The recent appointment of Larry Latowsky as Executive Chairman brings extensive industry experience from his tenure as President and CEO of Katz Group Canada, which is anticipated to drive sustainable growth in Doseology's oral stimulant platform and enhance market competitiveness.
- Equity Incentive Program: The company granted 140,000 restricted share units and 210,000 performance share units to a director, with the vesting schedule spread over 36 months, aimed at attracting and retaining executive talent to support the company's long-term strategic goals.
See More
Cannell Capital Sells Shares of Turning Point Brands
- Share Sale Overview: Cannell Capital reported the sale of 128,224 shares of Turning Point Brands in its February 17, 2026 SEC filing, with an estimated transaction value of $12.54 million, reflecting the company's strong performance in Q4 2025.
- Asset Management Impact: Following the sale, Turning Point Brands now constitutes 2.73% of Cannell Capital's 13F reportable AUM, while the fund's quarter-end position dropped by $12.18 million, indicating the impact of market fluctuations on its portfolio.
- Company Performance Highlights: Turning Point Brands achieved net sales of approximately $463 million in 2025, a 28% increase year-over-year, with net income of $58 million, showcasing strong cash flow in the rolling papers and alternative tobacco products sector.
- Investor Outlook Analysis: This share sale may represent Cannell Capital's strategy to lock in gains after a strong performance, and while reducing the position to below 3% does not imply abandonment of the long-term view, future growth will depend on brand durability and pricing power.
See More
Turning Point Brands Reports 29% Revenue Growth in Q4
- Significant Revenue Growth: Turning Point Brands reported a 29% increase in revenue for Q4, reaching $121 million, demonstrating strong market performance, particularly in the rapidly expanding Modern Oral product segment.
- Adjusted EBITDA Improvement: The company’s adjusted EBITDA rose by 14% to $30 million, reflecting enhanced operational efficiency and profitability, further solidifying its position in a competitive market.
- Surge in Modern Oral Sales: Net sales for Modern Oral products skyrocketed by 266% year over year to $41.3 million, indicating successful positioning in this emerging market, which is expected to drive sustained growth moving forward.
- Market Investments and Challenges: Despite a 13% decline in Zig-Zag sales, the company is actively investing in sales and marketing to counter potential tax increases and tariff impacts, thereby maintaining its competitive edge in the industry.
See More
Turning Point Brands Reports Q4 2025 Results, Shares Decline
- Earnings Decline: Turning Point Brands reported its Q4 2025 results, with CEO Graham Purdy indicating a potential for double-digit market share in the modern oral category, yet shares fell over 16.5%, reflecting market concerns about performance.
- Stable Cash Flows: Legacy brands like FRE and ALP continue to generate durable cash flows, providing financial stability for the company despite increasing competition in the modern oral products market.
- Dividend Increase: Last month, Turning Point raised its quarterly dividend from 7 cents to 8 cents per share, payable on April 10 to shareholders of record as of March 20, aiming to bolster investor confidence and attract more investment.
- Future Outlook: The company projects FY26 net revenue for the Modern Oral segment between $180 million and $190 million, with first-quarter adjusted EBITDA expected to be between $24 million and $27 million, indicating confidence in future growth despite market challenges.
See More
Analysis of Three High-Potential Dividend Stocks
- Turning Point Brands Growth Potential: Despite a slight dip in EPS, Turning Point Brands reported a 29% sales increase in Q4, exceeding analyst expectations by 9%, with modern oral nicotine product sales surging 266% year-over-year, indicating strong growth potential during its transition.
- Crown Holdings Dividend Increase: Crown Holdings announced a 35% dividend increase, achieving approximately $2.1 billion in adjusted EBITDA and $12.365 billion in net sales for 2025, reflecting strong performance in global beverage can demand and confidence in sustainable growth.
- Mondelez Undervalued: Mondelez generated $38.5 billion in revenue in 2025, and despite a 44.7% drop in EPS due to rising cocoa prices, its organic revenue still grew by 4.3%, showcasing strong growth potential in emerging markets and stable cash flow.
- Dividend Investment Opportunities: All three companies demonstrate robust cash flows and solid financial health, with dividend increases from Turning Point Brands and Crown Holdings reflecting management's confidence in future prospects, making them attractive for long-term investors.
See More
Apis Capital Increases Stake in Turning Point Brands Significantly
- Stake Increase: Apis Capital Advisors increased its position in Turning Point Brands by 106,948 shares in Q4 2026, with an estimated transaction value of $10.46 million, raising its stake from 1.3% to 3.1%, indicating strong confidence in the company's growth prospects.
- Market Value Growth: As of March 4, 2026, Turning Point Brands' shares were priced at $97.58, up 38.6% over the past year, outperforming the S&P 500 by 21 percentage points, reflecting market recognition of its strategic transformation.
- Revenue Growth Potential: The company's white nicotine pouch brands, Fre and Alp, achieved a remarkable 266% sales growth in Q4, projected to account for half of total revenue by the end of 2026, highlighting its competitive strength in a rapidly expanding market.
- Valuation Reasonableness: Despite Turning Point Brands' stock selling off over 30% from its Q1 highs, it trades at a forward P/E of 27 times while achieving 29% sales growth in the latest quarter, indicating a reasonably priced growth story that continues to attract investor interest.
See More
Doseology Launches New Energy Pouches Targeting Market Opportunities
- Market Growth Potential: The global oral nicotine pouch market is projected to grow from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR, indicating strong consumer demand for smoke-free alternatives and driving investments and innovations from companies like Doseology.
- Product Innovation and Market Testing: Doseology's launch of Feed That Brain energy pouches in the U.S. marks its first direct-to-consumer initiative, aiming to provide sugar-free, smoke-free energy supplements, signifying the company's strategic positioning in the non-nicotine energy product sector, expected to attract health-conscious consumers.
- Strategic Leadership Change: The recent appointment of Larry Latowsky as Executive Chairman brings extensive industry experience from his tenure as President and CEO of Katz Group Canada, which is anticipated to drive sustainable growth in Doseology's oral stimulant platform and enhance market competitiveness.
- Equity Incentive Program: The company granted 140,000 restricted share units and 210,000 performance share units to a director, with the vesting schedule spread over 36 months, aimed at attracting and retaining executive talent to support the company's long-term strategic goals.
See More
Cannell Capital Sells Shares of Turning Point Brands
- Share Sale Overview: Cannell Capital reported the sale of 128,224 shares of Turning Point Brands in its February 17, 2026 SEC filing, with an estimated transaction value of $12.54 million, reflecting the company's strong performance in Q4 2025.
- Asset Management Impact: Following the sale, Turning Point Brands now constitutes 2.73% of Cannell Capital's 13F reportable AUM, while the fund's quarter-end position dropped by $12.18 million, indicating the impact of market fluctuations on its portfolio.
- Company Performance Highlights: Turning Point Brands achieved net sales of approximately $463 million in 2025, a 28% increase year-over-year, with net income of $58 million, showcasing strong cash flow in the rolling papers and alternative tobacco products sector.
- Investor Outlook Analysis: This share sale may represent Cannell Capital's strategy to lock in gains after a strong performance, and while reducing the position to below 3% does not imply abandonment of the long-term view, future growth will depend on brand durability and pricing power.
See More
Turning Point Brands Reports 29% Revenue Growth in Q4
- Significant Revenue Growth: Turning Point Brands reported a 29% increase in revenue for Q4, reaching $121 million, demonstrating strong market performance, particularly in the rapidly expanding Modern Oral product segment.
- Adjusted EBITDA Improvement: The company’s adjusted EBITDA rose by 14% to $30 million, reflecting enhanced operational efficiency and profitability, further solidifying its position in a competitive market.
- Surge in Modern Oral Sales: Net sales for Modern Oral products skyrocketed by 266% year over year to $41.3 million, indicating successful positioning in this emerging market, which is expected to drive sustained growth moving forward.
- Market Investments and Challenges: Despite a 13% decline in Zig-Zag sales, the company is actively investing in sales and marketing to counter potential tax increases and tariff impacts, thereby maintaining its competitive edge in the industry.
See More
Turning Point Brands Reports Q4 2025 Results, Shares Decline
- Earnings Decline: Turning Point Brands reported its Q4 2025 results, with CEO Graham Purdy indicating a potential for double-digit market share in the modern oral category, yet shares fell over 16.5%, reflecting market concerns about performance.
- Stable Cash Flows: Legacy brands like FRE and ALP continue to generate durable cash flows, providing financial stability for the company despite increasing competition in the modern oral products market.
- Dividend Increase: Last month, Turning Point raised its quarterly dividend from 7 cents to 8 cents per share, payable on April 10 to shareholders of record as of March 20, aiming to bolster investor confidence and attract more investment.
- Future Outlook: The company projects FY26 net revenue for the Modern Oral segment between $180 million and $190 million, with first-quarter adjusted EBITDA expected to be between $24 million and $27 million, indicating confidence in future growth despite market challenges.
See More
